Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR

Journal of the Society for Gynecologic Investigation

Volumn 6, Issue 2, 1999, Pages 64-69

  Bischoff, Farideh Z ^a   Nguyen, Dianne D ^a   Marquéz Do, Deborah ^a   Moise Jr, Kenneth J ^a   Simpson, Joe Leigh ^a   Elias, Sherman ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Fetal RhD; Maternal serum DNA; Noninvasive prenatal diagnosis; Polymerase chain reaction

Indexed keywords

DNA; RHESUS D ANTIGEN;

ARTICLE; BASE PAIRING; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; HUMAN; MATERNAL SERUM; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

BLOOD GROUPING AND CROSSMATCHING; DNA; FEMALE; FETAL BLOOD; HUMANS; POLYMERASE CHAIN REACTION; PREGNANCY; RETROSPECTIVE STUDIES; RH-HR BLOOD-GROUP SYSTEM; SENSITIVITY AND SPECIFICITY;

EID: 0032935047     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(98)00051-3     Document Type: Article

References (22)

1. Agre P., Cartron J.P. Molecular biology of the Rh antigens. Blood. 78:1991;551-563.
2. Bowman J.M. Hemolytic disease (erythroblastosis fetalis). Creasy R.K., Resnik R. Maternal-fetal medicine. Principles and practice. 3rd ed. 1984;711-743 WB Saunders, Philadelphia.
3. Cherif-Zahar B., Bloy C., Le Van Kim C., et al. Molecular cloning and protein structure of a human Rh polypeptide. Proc Natl Acad Sci USA. 87:1990;6243-6247.
4. Colin Y., Cherif-Zahar B., Le Van Kim C., Raynal V., van Huffel V., Carton J.P. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood. 78:1991;2747-2752.
5. Le Van Kim C., Mouro I., Cherif-Zahar B., et al. Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc Natl Acad Sci USA. 89:1992;10925-10929.
6. Bennett P.R., Kim C.L., Colin Y., et al. Prenatal determination of fetal RhD type by DNA amplification following chorion villus biopsy or amniocentesis. N Engl J Med. 329:1993;607-610.
7. Fisk N.M., Bennett P., Warwick R.M., et al. Clinical utility of fetal RhD typing in alloimmunized pregnancies by means of polymerase chain reaction on amniocytes or chorionic villi. Am J Obstet Gynecol. 171:1994;50-54.
8. Lighten A.D., Overton T.G., Warwick R.M., Sepulveda W., Fisk N.M., Bennett P.R. Accuracy of prenatal determination of RhD type status by polymerase chain reaction with amniotic cells. Am J Obstet Gynecol. 173:1995;1182-1185.
9. Sagot P., Bonneville F., Bignon J.D., Cesbron A., Boog G., Muller J.Y. Management of platelet and RhD maternal immunizations by PCR phenotyping after early amniocentesis. Fetal Diagn Ther. 10:1995;373-380.
10. Rossiter J.P., Blakemore K.J., Kicler T.S., et al. The use of polymerase chain reaction to determine fetal RhD status. Am J Obstet Gynecol. 171:1994;1047-1051.
11. Van den Veyver I.B., Subramanian S.B., Hudson K.M., Werch J., Moise K.J., Hughes M.R. Prenatal diagnosis of the RhD fetal blood type on amniotic fluid by polymerase chain reaction. Obstet Gynecol. 87:1996;419-422.
12. Spence W.C., Maddalena A., Demers D.B., Bick D.P. Molecular analysis of the RhD genotype in fetuses at risk for RhD hemolytic disease. Obstet Gynecol. 85:1995;296-298.
13. Queenan J.T., Tomai T.P., Ural S.H., King J.C. Deviation in the amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation A proposal for clinical management . Am J Obstet Gynecol. 168:1993;1370-1376.
14. Lo Y.M.D., Corbetta N., Chamberlain P.F., et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 350:1997;485-487.
15. Lo Y.M.D., Tein M.S., Lau T.K., et al. Quantitative analysis of fetal DNA in maternal plasma and serum Implications for noninvasive prenatal diagnosis . Am J Hum Genet. 62:1998;768-775.
16. Findlay I., Quirke P. Fluorescent polymerase chain reaction Part I. A new method allowing genetic diagnosis and DNA fingerprinting of single cells . Hum Reprod Update. 2:1996;137-152.
17. Hattori M., Yoshioka K., Sakaki Y. Highly sensitive fluorescent DNA sequencing and its application for detection and mass-screening of point mutations. Electrophoresis. 13:1992;560-565.
18. Aubin J.T., Le Van Kim C., Mouro I., et al. Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification. Br J Haematol. 98:1997;356-364.
19. Cartron J.P. Defining the Rh blood group antigens biochemistry and molecular genetics . Blood Rev. 8:1994;199-212.
20. Kemp T.J., Poulter M., Carritt B. A recombination hot spot in the Rh genes revealed by analysis of unrelated donors with the rare D phenotype. Am J Hum Genet. 59:1996;1066-1073.
21. Matassi G., Cherif-Zahar B., Mouro I., Cartron J.P. Characterization of the recombination hot spot involved in the genomic rearrangement leading to the hybrid D-CE-D gene in the D(VI) phenotype. Am J Hum Genet. 60:1997;808-817.
22. Avent N.D., Jones J.W., Liu W., et al. Molecular basis of the D variant phenotypes DNU and DII allows localization of critical amino acids required for expression of Rh D epitopes epD3, 4 and 9 to the sixth external domain of the Rh D protein. Br J Haematol. 97:1997;366-371.